IP Library Granted Patent US 8,377,143
Granted Patent B2
US 8,377,143 · App. 12/831,053 · Granted Feb 19, 2013

Tissue implants for implantation and methods for preparing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,377,143
App. No.
12/831,053
Granted
Feb 19, 2013
Kind
B2
Abstract

A method is provided for preparing a tissue implant for implantation. The method includes harvesting a tissue material from a human or an animal donor, treating the tissue material in a nuclease-containing solution, and thereafter treating the tissue material with an alkaline alcohol solution. The nuclease-containing solution includes an antimicrobial. The alkaline alcohol solution comprises sodium hydroxide and ethanol.

Claims (30)

1. A method of preparing a tissue implant for implantation comprising:

treating a tissue material in a nuclease-containing solution, the nuclease-containing solution comprising an antibiotic-free antimicrobial, wherein the antibiotic-free antimicrobial comprises benzyl alcohol and the benzyl alcohol is present in the nuclease-containing solution in a concentration of 0.8 to about 2.0% v/v; and

treating the tissue material with an alkaline alcohol solution.

2. The method of claim 1 , wherein the nuclease-containing solution comprises DNase or RNase or a combination thereof.

3. The method of claim 1 , wherein the alkaline alcohol solution comprises ethanol.

4. The method of claim 1 , wherein the alkaline alcohol solution comprises sodium hydroxide.

5. A method of preparing a tissue implant for implantation comprising:

treating a tissue material in a nuclease-containing solution, the nuclease-containing solution comprising an antibiotic-free antimicrobial; and

treating the tissue material with an alkaline alcohol solution comprising ethanol, wherein the ethanol is present in a concentration of about 72 to about 88 percent v/v.

6. A method of preparing a tissue implant for implantation comprising:

treating a tissue material in a nuclease-containing solution, the nuclease-containing solution comprising an antibiotic-free antimicrobial; and

treating the tissue material with an alkaline alcohol solution comprising sodium hydroxide, wherein the alkaline alcohol solution is about 0.016 M to about 0.022 M sodium hydroxide.

7. A method of preparing a tissue implant for implantation comprising:

treating a tissue material in a nuclease-containing solution, the nuclease-containing solution comprising benzyl alcohol, which is present in the nuclease-containing solution in a concentration of 0.8 to about 2.0% v/v.

8. The method of claim 7 , wherein the nuclease-containing solution comprises DNase or RNase or a combination thereof.

9. A method of preparing a tissue implant for implantation comprising:

harvesting a tissue material from a human or an animal donor;

treating the tissue material in a nuclease-containing solution, the nuclease-containing solution comprising an antibiotic-free antimicrobial; and thereafter

treating the tissue material with an alkaline alcohol solution, which comprises sodium hydroxide and ethanol, wherein the alkaline alcohol comprises ethanol in a concentration of about 72 to about 88 percent v/v and 0.016 M to about 0.022 M sodium hydroxide.

10. The method of claim 9 , wherein the tissue material comprises human, bovine, or equine pericardium.

11. The method of claim 9 , wherein the antibiotic-free antimicrobial comprises benzyl alcohol.

12. A method of preparing a tissue implant for implantation comprising:

harvesting a tissue material from a human or an animal donor;

treating the tissue with a hypotonic solution to initiate cellular lysis;

treating the tissue material in a nuclease-containing solution, the nuclease-containing solution comprising benzyl alcohol present in the nuclease-containing solution in a concentration of 0.8 to about 2.0% v/v;

treating the tissue material with an alkaline alcohol solution comprising ethanol and sodium hydroxide, wherein the alkaline alcohol comprises ethanol in a concentration of about 72 to about 88 percent v/v and 0.016 M to about 0.022 M sodium hydroxide;

treating the tissue material with chlorine dioxide;

treating the tissue material with an antioxidant;

vacuum-sealing the tissue material in a package; and

irradiating the vacuum-sealed tissue material.

Assignments (8)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
SECURITY INTEREST Recorded Jan 18, 2024
From: ARTIVION, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 066159/0893 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →
SECURITY AGREEMENT Recorded Oct 31, 2011
From: CRYOLIFE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 027146/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: HAMBY, JOSEPH; WALSH, STEVEN
To: CYROLIFE, INC.
Reel/Frame 024898/0786 →